Human Leukocyte Antigen Genes and Interferon Beta Preparations Influence Risk of Developing Neutralizing Anti-Drug Antibodies in Multiple Sclerosis

• Jenny Link ,

  Contributed equally to this work with: Jenny Link, Malin Lundkvist Ryner

  Affiliation Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Malin Lundkvist Ryner ,

  Contributed equally to this work with: Jenny Link, Malin Lundkvist Ryner

  * E-mail: malin.ryner@ki.se

  Affiliation Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Katharina Fink,

  Affiliation Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Christina Hermanrud,

  Affiliation Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Izaura Lima,

  Affiliation Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Boel Brynedal,

  Affiliation Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Ingrid Kockum,

  Affiliation Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Jan Hillert,

  Affiliation Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Anna Fogdell-Hahn

  Affiliation Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

  ⨯